Business Medical Dialogues
    • facebook
    • twitter
    Login Register
    • facebook
    • twitter
    Login Register
    • Medical Dialogues
    • Speciality Dialogues
    • Education Dialogues
    • Medical Jobs
    • Medical Matrimony
    • MD Brand Connect
    Business Medical Dialogues
    • News
        • Financial Results
        • Hospitals & Diagnostics
        • IT / Health Venture
        • Implants / Devices
        • Insurance
        • Key Movement
        • Pharmaceuticals
        • Policy
        • Technology
        • pharma-news
    • blog
    LoginRegister
    Business Medical Dialogues
    LoginRegister
    • Home
    • News
      • Financial Results
      • Hospitals & Diagnostics
      • IT / Health Venture
      • Implants / Devices
      • Insurance
      • Key Movement
      • Pharmaceuticals
      • Policy
      • Technology
      • pharma-news
    • blog
    • Home
    • Editors Pick

    Editors Pick - Page 124

    Daiichi versus Singh Brothers: Daiichi Sankyo demands third party Audit

    Daiichi versus Singh Brothers: Daiichi Sankyo demands third party Audit

    savita thakur thakur1 April 2017 9:34 AM IST
    Japanese firm Daiichi Sankyo wants a third party auditor inspect the financial details disclosed by former owners of Ranbaxy Malvinder Singh and...
    Gleneagles Global Hospitals to Invest Rs 200 Crore for Expansion

    Gleneagles Global Hospitals to Invest Rs 200 Crore for Expansion

    savita thakur thakur31 March 2017 6:01 PM IST
    Planning to make its presence dominant and stronger in Indian healthcare industry in the future, Gleneagles Global Hospitals is all set to invest Rs...
    Panacea Biotec launches vaccine for newborns

    Panacea Biotec launches vaccine for newborns

    supriya kashyap kashyap31 March 2017 4:48 PM IST
    New Delhi : Drug firm Panacea Biotec announced launch of EasySix, a liquid hexavalent combination vaccine indicated for immunisation of newborn babies...
    Kerala Institute of Medical Sciences gets Rs 1300 crore investment from True North

    Kerala Institute of Medical Sciences gets Rs 1300 crore investment from True North

    supriya kashyap kashyap30 March 2017 11:18 AM IST
    Mumbai : In one of the largest healthcare transactions in India, the Kerala Institute of Medical Sciences (KIMS) will get USD 200 million from True...
    FDA approves Dupixent to treat Atopic Dermatitis

    FDA approves Dupixent to treat Atopic Dermatitis

    supriya kashyap kashyap30 March 2017 9:18 AM IST
    The U.S. Food and Drug Administration approved Dupixent (dupilumab) injection to treat adults with moderate-to-severe eczema (atopic dermatitis)....
    NPPA identifies 634 suspected cases of overcharging

    NPPA identifies 634 suspected cases of overcharging

    supriya kashyap kashyap29 March 2017 11:59 AM IST
    New Delhi : National drug pricing regulator NPPA has identified 634 cases where non-compliance of notified ceiling prices is suspected, Parliament was...
    Temasek eyes to acquire 18 percent stake in Manipal Healthcare

    Temasek eyes to acquire 18 percent stake in Manipal Healthcare

    savita thakur thakur28 March 2017 1:52 PM IST
    Temasek Holdings Private Limited, a Singapore based investment company is looking forward to expand its holding in Indian healthcare sector and is...
    FDA approves maintenance treatment for recurrent epithelial ovarian, fallopian tube or primary peritoneal cancers

    FDA approves maintenance treatment for recurrent epithelial ovarian, fallopian tube or primary peritoneal cancers

    supriya kashyap kashyap28 March 2017 9:37 AM IST
    The U.S. Food and Drug Administration approved Zejula (niraparib) for the maintenance treatment (intended to delay cancer growth) of adult patients...
    Fortis Healthcare Said to Consider Buyout of Singapore Trust

    Fortis Healthcare Said to Consider Buyout of Singapore Trust

    savita thakur thakur27 March 2017 11:21 AM IST
    BloombergNew Delhi: Fortis Healthcare Ltd., India’s second-largest private hospital chain by market value, is weighing a buyout of the...
    Novartis, Abbott, Emcure face allegations of cartelisation in anti-diabetes drug Vildagliptin

    Novartis, Abbott, Emcure face allegations of cartelisation in anti-diabetes drug Vildagliptin

    savita thakur thakur26 March 2017 11:33 AM IST
    The Swiss drug maker Novartis and US based Abbott along with domestic companies Emcure and USV Pharma are under the lens of Health Ministry and...
    Mankind Pharma Invests Rs 305 crore to launch Diagnostic Venture-Pathkind

    Mankind Pharma Invests Rs 305 crore to launch Diagnostic Venture-Pathkind

    savita thakur thakur26 March 2017 11:29 AM IST
    NEW DELHI: After showing its worth in pharmaceutical industry, the Mankind pharma is all set to enter into the diagnostics market under its new...
    Pact to check misleading ads of Ayurvedic medicines

    Pact to check misleading ads of Ayurvedic medicines

    supriya kashyap kashyap26 March 2017 10:11 AM IST
    New Delhi : The government has signed a pact with the Advertising Standards Council of India to check misleading advertisements of Ayurvedic...
    PrevNext

    Popular Stories

    Ayurvedic Medicines for Blood Sugar, Diet containing Metformin Hydrochloride: Ayurveda Firm Booked

    Ayurvedic Medicines for Blood Sugar, Diet containing Metformin Hydrochloride: Ayurveda Firm Booked

    FDC Ban: Supreme Court Relief to Saridon, Piriton and Dart

    FDC Ban: Supreme Court Relief to Saridon, Piriton and Dart

    Illegal steroid smuggling ring allegedly led by India-based Alpha Pharma busted in UK

    Illegal steroid smuggling ring allegedly led by India-based Alpha Pharma busted in UK

    CDSCO bans OTC sale of topical medications containing hydroquinone from April 1, 2019

    CDSCO bans OTC sale of topical medications containing hydroquinone from April 1, 2019

    Government of India bans Ofloxacin, Ornidazole injection combination

    Government of India bans Ofloxacin, Ornidazole injection combination

    Rising prices of hydroxychloroquine raw material forces small scale pharmas in Haridwar to stop production

    Rising prices of hydroxychloroquine raw material forces small scale pharmas in Haridwar to stop...

    Union Pharma Secretary Holds video conference with Pharma manufacturers and associations, takes feedback

    Union Pharma Secretary Holds video conference with Pharma manufacturers and associations, takes...

    Pharma Export do not need NOC: CDSCO

    Pharma Export do not need NOC: CDSCO

    View All

    • Email: info@medicaldialogues.in
    • Phone: 011 - 4372 0751

    Website Last Updated On : 13 Oct 2022 5:14 AM GMT
    Company
    • About Us
    • Contact Us
    • Our Team
    • Reach our Editor
    • Feedback
    • Submit Article
    Ads & Legal
    • Advertise
    • Advertise Policy
    • Terms and Conditions
    • Privacy Policy
    • Editorial Policy
    • Comments Policy
    • Disclamier
    Medical Dialogues is health news portal designed to update medical and healthcare professionals but does not limit/block other interested parties from accessing our general health content. The health content on Medical Dialogues and its subdomains is created and/or edited by our expert team, that includes doctors, healthcare researchers and scientific writers, who review all medical information to keep them in line with the latest evidence-based medical information and accepted health guidelines by established medical organisations of the world.

    Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription.Use of this site is subject to our terms of use, privacy policy, advertisement policy. You can check out disclaimers here. © 2025 Minerva Medical Treatment Pvt Ltd

    © 2025 - Medical Dialogues. All Rights Reserved.
    Powered By: Hocalwire
    X
    We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok